BRCA2, ATM, and CDK12 Defects Differentially Shape Prostate Tumor Driver Genomics and Clinical Aggression-Reference-Cited by-同舟云学术

BRCA2, ATM, and CDK12 Defects Differentially Shape Prostate Tumor Driver Genomics and Clinical Aggression

Published:2021-01-07 Issue:6 Volume:27 Page:1650-1662
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Warner Evan,Herberts Cameron^ORCID,Fu Simon^ORCID,Yip Steven,Wong Amanda,Wang Gang^ORCID,Ritch Elie,Murtha Andrew J.^ORCID,Vandekerkhove Gillian^ORCID,Fonseca Nicolette M.,Angeles Arkhjamil^ORCID,Beigi Arshia,Schönlau Elena,Beja Kevin,Annala Matti,Khalaf Daniel^ORCID,Chi Kim N.,Wyatt Alexander W.^ORCID

Funder

Gouvernement du Canada | Canadian Institutes of Health Research

Prostate Cancer Canada

Prostate Cancer Foundation

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing olaparib efficacy in U.S. Veterans with metastatic prostate cancer utilizing a time-indifferent -rate method ideal for real-world analyses;eBioMedicine;2024-09

2. Combination of PARP Inhibitors and Androgen Receptor Pathway Inhibitors in Metastatic Castration-Resistant Prostate Cancer;Drugs;2024-07-26

3. A novel prognostic model of de novo metastatic hormone-sensitive prostate cancer to optimize treatment intensity;International Journal of Clinical Oncology;2024-07-19

4. Complete remission following pembrolizumab in a man with mCRPC with both microsatellite instability and BRCA2 mutation;The Oncologist;2024-06-26

5. Somatic Tumor Testing in Prostate Cancer: Experience of a Tertiary Care Center Including Pathologist-Driven Reflex Testing of Localized Tumors at Diagnosis;Modern Pathology;2024-06